Menu
Recruiting NCT07352111

High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction

No phase Interventional Coronary Artery Diease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Cardiac CT.
Who it may be relevant to
Registry conditions: Coronary Artery Diease. Basic parameters: 40 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction; the FAMILY Study

Overview

The evidence of high-risk atherosclerosis at cardiac CT (CCT) may support aggressive primary prevention treatment, reducing the risk of future cardiovascular events. Family history of coronary artery disease (CAD) is a risk factor for cardiovascular events but limited data described the prevalence of coronary atherosclerosis in these patients. Aims of the FAMILY project are to explore the prevalence of high-risk coronary atherosclerosis among patients with family history of CAD, to explore whether CCT in this setting may to reclassify patients' vs standard of care and to explore correlations between genetic background and high risk and potentially unstable coronary atherosclerosis. A consecutive cohort of asymptomatic of patients with family history of CAD will be prospectively enrolled. A per-protocol CCT with advanced atherosclerosis analysis will be performed. At the time of CCT a blood sample will be collected for bio-humoral and genetic investigation. The prevalence of high risk atherosclerosis will be quantified, the reclassification rate of CCT vs clinical evaluation evaluated and the potential in vivo association between genetic profile and high risk atherosclerosis explored.

Interventions

  • Diagnostic test Cardiac CT
    Cardiac CT with advance plaque evaluation will be performed

Primary outcome measures

  • Risk reclassification [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

  • patients with postive family history of CAD

Exclusion criteria

  • known cardiovascular diseases
  • any symptoms

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

Italy · 1 center
  • Ospedale Galeazzi-Sant'Ambrogio IRCCS — Milan

Identifiers

NCT: NCT07352111 · FAMILY Study

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗